Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 55 references it cites were found in a registry or an index; 12 of the 57 sources its claims cite were checked for support.

Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test

Open access

Abstract

Context: Adrenal insufficiency (AI) is usually diagnosed by low plasma cortisol levels following a short Synacthen test (SST). Most plasma cortisol is bound to corticosteroid-binding globulin, which is increased by estrogen in combined estrogen-progestin oral contraceptives (COCs). Women with AI using COCs are therefore at risk of having an apparently normal plasma cortisol level during SST, which would not adequately reflect AI. Objective: This work aimed to test whether salivary cortisol or cortisone during SST is more robust against the COC effect and to calculate the lower reference limits (LRLs) for these to be used as tentative diagnostic cutoffs to exclude AI. Methods: Forty-one healthy women on COCs and 46 healthy women without exogenous estrogens underwent an SST with collection of plasma and salivary samples at 0, 30, and 60 minutes after Synacthen injection. The groups were compared using regression analysis with age as covariate and the LRLs were calculated parametrically. Results: SST-stimulated plasma cortisol levels were significantly higher in the COC group vs controls, while mean salivary cortisol and cortisone levels were slightly lower in the COC group. Importantly, COC use did not significantly alter LRLs for salivary cortisol or cortisone. The smallest LRL difference between groups was seen for salivary cortisone. Conclusion: Salivary cortisol and especially salivary cortisone are considerably less affected by COC use than plasma cortisol during SST. Due to similar LRLs, a common cutoff for salivary cortisol and cortisone during SST can be used to exclude AI in premenopausal women irrespective of COC use.

Overview

CoChat Summary

TL;DR

In healthy women undergoing a short Synacthen test (SST), salivary cortisol and especially salivary cortisone were much less affected by combined oral contraceptive (COC) use than plasma cortisol. The authors propose common salivary cutoffs to exclude adrenal insufficiency irrespective of COC use.

Key findings

  • Plasma cortisol after SST was significantly higher in COC users than controls at baseline (910 vs 360 nmol/L), 30 min (1180 vs 620 nmol/L), and 60 min (1310 vs 707 nmol/L; all P < .001).
  • Salivary cortisol and cortisone were slightly lower in COC users at 30 and 60 min; e.g., salivary cortisol at 60 min was 43.2 vs 48.4 nmol/L (P = .011), and salivary cortisone at 60 min was 78.0 vs 83.8 nmol/L (P = .035).
  • Lower reference limits (LRLs) for salivary cortisol and cortisone did not differ significantly between COC users and controls by bootstrap simulation. At 60 min, salivary cortisone LRLs were 48.1 vs 48.8 nmol/L, while plasma cortisol LRLs were 870 vs 566 nmol/L.
  • The authors suggest salivary cortisone above 37 nmol/L at 30 min or above 49 nmol/L at 60 min, and salivary cortisol above 17 nmol/L at 30 min or above 26 nmol/L at 60 min, are likely to exclude adrenal insufficiency regardless of COC use.

Methods

  • Prospective study of 89 recruited healthy women aged 18–50; after exclusions, 41 women using monophasic ethinylestradiol-containing COCs and 46 nonusers of estrogens underwent a standard SST with 250 µg Synacthen.
  • Plasma and salivary samples were collected at 0, 30, and 60 min. Plasma cortisol was measured by Roche Elecsys Cortisol II; salivary cortisol and cortisone were measured by LC-MS/MS.
  • Groups were compared using regression with age as covariate; LRLs were calculated parametrically using the UMVUE method, with bootstrap simulation to test differences between LRLs.

Limitations

  • The paper states that the study had a limited number of observations, that diagnostic accuracy in patients with suspected adrenal insufficiency still needs evaluation, and that the cutoffs cannot immediately be extrapolated to other analytical methods, pregnancy, low-CBG states, postmenopausal women, or men.
  • The paper notes that the age-related decrease in cortisol measures was unexpected and warrants further study, and that progestin-type findings were based on low numbers and should be interpreted cautiously.
  • Evident from the text: participants were healthy women, not patients with adrenal insufficiency, so sensitivity and specificity of the proposed salivary cutoffs were not directly assessed.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1210/clinem/dgad763

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Individual responses to Synacthen at 0, 30, and 60 minutes for plasma cortisol, salivary cortisol, and salivary cortisone. Red triangles indicate participants in the combined oral contraceptives group and black circles indicate those in the control group.
Figure 1. Individual responses to Synacthen at 0, 30, and 60 minutes for plasma cortisol, salivary cortisol, and salivary cortisone. Red triangles indicate participants in the combined oral contraceptives group and black circles indicate those in the control group.CC BY · PubMed Central
Figure 2. Box plots showing each individual's measurements of plasma cortisol, salivary cortisol, and salivary cortisone following the Synacthen test. Whiskers denote the range, wide dashed black lines denote lower reference limits, and blue boxes around the lower whiskers represent the 90% CIs at A, 30 and B, 60 minutes. Gray boxes indicate participants on combined oral contraceptives (COCs) and white boxes controls (CTRL). *P less than .05; ***P less than .001 for comparison of mean values.
Figure 2. Box plots showing each individual's measurements of plasma cortisol, salivary cortisol, and salivary cortisone following the Synacthen test. Whiskers denote the range, wide dashed black lines denote lower reference limits, and blue boxes around the lower whiskers represent the 90% CIs at A, 30 and B, 60 minutes. Gray boxes indicate participants on combined oral contraceptives (COCs) and white boxes controls (CTRL). *P less than .05; ***P less than .001 for comparison of mean values.CC BY · PubMed Central
Figure 3. Pivot point around 500 nmol/L for plasma cortisol is seen for controls, where a sharp increase in salivary cortisol A, and salivary cortisone B, occurs. No pivot point was seen for the combined oral contraceptives (COC) group.
Figure 3. Pivot point around 500 nmol/L for plasma cortisol is seen for controls, where a sharp increase in salivary cortisol A, and salivary cortisone B, occurs. No pivot point was seen for the combined oral contraceptives (COC) group.CC BY · PubMed Central
Figure 4. Salivary cortisol:cortisone relationship as concentrations increase. A pivot point of 11.7 nmol/L (dashed vertical line) for salivary cortisol is shown in the control group A, after which salivary cortisol increases more than salivary cortisone. No pivot point was found for the combined oral contraceptive (COC) group, B.
Figure 4. Salivary cortisol:cortisone relationship as concentrations increase. A pivot point of 11.7 nmol/L (dashed vertical line) for salivary cortisol is shown in the control group A, after which salivary cortisol increases more than salivary cortisone. No pivot point was found for the combined oral contraceptive (COC) group, B.CC BY · PubMed Central

Verification

Claims the paper makes

7 Valid · 1 Not valid · 12 Not checked · 50 Own results and interpretations

44 more claims

Create a free account to see all 70 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 13
  • Probably not a substantial claim. 11

Create a free account to see these claims.

Citations

Cites

Show all 55 references

Research works printed but not linked: 1

  1. Horowitz, 2010, Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline—Third Edition

Cited by

See all 13

Metadata

Authors
Bäcklund, N., Lundstedt, S., Tornevi, A., Wihlbäck, A.-C., Olsson, T., Dahlqvist, P., & Brattsand, G.
Affiliations
Umeå University (SE)
Corresponding author
Bäcklund, Nils
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2024-01-04
Volume
109
Issue
7
Pages
1899-1906
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W4390584301
Cited by
13
References
55
Citations by year
2026: 6 · 2025: 3 · 2024: 4
FWCI
4.25
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DiVA at Umeå University (Umeå University) (submittedVersion, other-oa)
Funders
  • Västerbotten County Council
  • Umeå University
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
Keywords
adrenal insufficiency, ACTH stimulation test, salivary cortisol, salivary cortisone, oral contraceptives, corticosteroid-binding globulin, estrogen, diagnostic thresholds, premenopausal women, confounding
MeSH terms
Adrenal Insufficiency, Adult, Contraceptives, Oral, Contraceptives, Oral, Combined, Cortisone, Cosyntropin, Female, Humans, Hydrocortisone, Reference Values, Saliva, Case-Control Studies, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test. https://app.cochat.ai/papers/10.1210/clinem/dgad763
The paper
Bäcklund, N., Lundstedt, S., Tornevi, A., Wihlbäck, A.-C., Olsson, T., Dahlqvist, P., & Brattsand, G. (2024). Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad763

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.